About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
731 genotypes with 927 annotations displayed of selected term and subterms
Searched Term: increased lymphoma incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\Abraxas1tm1.1Bwng/\Abraxas1+
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased histiocytic sarcoma incidence J:269823
increased lymphoma incidence J:269823
\Abraxas1tm1.1Bwng/\Abraxas1tm1.1Bwng
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased lymphoma incidence J:269823
\Abraxas2tm1.2Bwng/\Abraxas2+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl) 		increased lymphoma incidence J:245949
\Abraxas2tm1.2Bwng/\Abraxas2tm1.2Bwng
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl) 		increased lymphoma incidence J:245949
\Aicdatm1(cre)Mnz/\Aicda+
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
increased follicular lymphoma incidence J:153656
increased T cell derived lymphoma incidence J:153656
\Airetm1Pltn/\Airetm1Pltn
(B6.129S4-Airetm1Pltn) 		increased B cell derived lymphoma incidence J:115076
\Aktiptm1a(EUCOMM)Hmgu/\Aktiptm1a(EUCOMM)Hmgu
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:276210
\Aktiptm1a(EUCOMM)Hmgu/\Aktiptm1a(EUCOMM)Hmgu
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:276210
\Aldh2tm1a(EUCOMM)Wtsi/\Aldh2tm1a(EUCOMM)Wtsi
\Fancd2tm1Hou/\Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N) 		increased lymphoma incidence J:193232
increased T cell derived lymphoma incidence J:193232
\Anxa7tm1Pll/\Anxa7+
(B6.Cg-Anxa7tm1Pll) 		increased lymphoma incidence J:93685
\Apctm1Rak/\Apc+
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:53451
\Apex1tm1Ecf/\Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		increased lymphoma incidence J:70397
\Atad5Gt(RRF055)Byg/\Atad5+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:176672
increased T cell derived lymphoma incidence J:176672
\Atmtm1.1Mmpl/\Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:226414
\Atmtm1Awb/\Atm+
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Atmtm1Awb/\Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		increased T cell derived lymphoma incidence J:34193
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell derived lymphoma incidence J:103922
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
\Atmtm1Awb/\Atmtm1Awb
(CByJ.129S6-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x B6.129S6-Atmtm1Awb)F1 or (B6.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x A.129S6-Atmtm1Awb)F1 or (A.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J) 		increased T cell derived lymphoma incidence J:226414
\Atmtm1Awb/\Atmtm1Awb
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Atmtm1Awb/\Atmtm1Awb
\Rad52tm1Aps/\Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
\Atmtm1Bal/\Atmtm1Bal
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:35914
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:61201
\Atmtm1Led/\Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		increased T cell derived lymphoma incidence J:69726
\Atmtm1Mfl/\Atm+
(involves: 129T2/SvEms * C57BL/6J) 		increased lymphoma incidence J:78527
\Atmtm1Mfl/\Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J) 		increased T cell derived lymphoma incidence J:69726
\Atmtm1Pmc/\Atmtm1Pmc
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:47752
\Atmtm2.1Fwa/\Atmtm2.1Fwa
\Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:277750
\Atmintm1.1Jhh/\Atmintm1.1Jhh
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(IghMyc)22Bri/0
(B6.Cg-Bcl2l11tm1.1Ast Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri) 		increased lymphoma incidence J:230105
\AurkaGt(XQ0149)Wtsi/\Aurka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:143099
\B2mtm1Unc/\B2mtm1Unc
\Prkdcscid/\Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid) 		increased T cell derived lymphoma incidence J:102141
\Badtm1Sjk/\Badtm1Sjk
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6)) 		increased B cell derived lymphoma incidence J:84987
increased lymphoma incidence J:84987
\Bap1em3Test/\Bap1+
(involves: FVB) 		increased lymphoma incidence J:231692
\Bcl2tm2.1Lbox/\Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
\Bcl2tm2.1Lbox/\Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
\Bcl2l11tm1.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
increased T cell derived lymphoma incidence J:186117
\Bcl2l11tm1.1Boui/\Bcl2l11tm1.1Boui
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
\Bcl2l11tm2.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
\Bcl2l11tm2.1Boui/\Bcl2l11tm2.1Boui
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
\Bcl2l11tm3.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
\Bcl2l11tm3.1Boui/\Bcl2l11tm3.1Boui
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
\Bcl11btm2.1Jpk/\Bcl11b+
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		increased lymphoma incidence J:210122
\Becn1tm1Blev/\Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased follicular lymphoma incidence J:86953
increased histiocytic sarcoma incidence J:86953
increased lymphoma incidence J:86953
\Becn1tm1Htz/\Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:86982
\Bin1tm1Gcp/\Bin1tm2Gcp
\Tg(MMTV-Myc)141-3Led/0
\Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased lymphoma incidence J:117330
\Bin3tm1Gcp/\Bin3tm1Gcp
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:133313
\Blmtm1Ches/\Blmtm3Brd
(involves: 129S/SvEv * C57BL/6 * NIH Black Swiss) 		increased lymphoma incidence J:86827
\Blmtm3Brd/\Blmtm3Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:66261
\Blnktm1Pjln/\Blnktm1Pjln
\Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:94768
\Bmftm1.1Ast/\Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst) 		increased T cell derived lymphoma incidence J:133084
\Boktm1.1Ast/\Boktm1.1Ast
\Tg(IghMyc)22Bri/0
(involves: BALB/cJ * C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:203179
\Bomb1NSF/N/\Bomb1NSF/N
(involves: NFS/N * SL/Kh) 		increased lymphoma incidence J:55364
\Bomb1SL/Kh/\Bomb1SL/Kh
(involves: NFS/N * SL/Kh) 		increased lymphoma incidence J:55364
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:81541
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:81541
\Brca1tm2Mak/\Brca1tm2Mak
\Chek2tm1Mak/\Chek2tm1Mak
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
\Brca1tm3Cxd/\Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:94114
\Brca1tm5.1Cxd/\Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:155810
increased T cell derived lymphoma incidence J:155810
\Brca2tm1Cam/\Brca2tm1Cam
(involves: 129S/SvEv * MF1) 		increased T cell derived lymphoma incidence J:46812
\Brca2tm1Cbl/\Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)) 		increased T cell derived lymphoma incidence J:44386
\Brca2tm1Hst/\Brca2tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:82434
\Brca2tm1Mak/\Brca2tm2Mak
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased lymphoma incidence J:79697
\Brip1Gt(RRI409)Byg/\Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:227115
\Bub1tm1.1Jvd/\Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:135093
\Bub1btm1.1Hsl/\Bub1b+
(involves: 129 * C57BL/6) 		increased B cell derived lymphoma incidence J:201641
increased lymphoma incidence J:201641
\Ccnctm1.1Pisc/\Ccnctm1.1Pisc
\Tg(Lck-LMO1)11Sjk/0
\Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:217695
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased T cell derived lymphoma incidence J:88120
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:160931
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:228288
\Cd19tm1(cre)Cgn/\Cd19+
\Inpp5dtm1Rav/\Inpp5dtm1Rav
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased follicular lymphoma incidence J:166155
increased lymphoma incidence J:166155
increased splenic marginal zone lymphoma incidence J:166155
\Cd19tm1(cre)Cgn/\Cd19+
\Mirc30tm1.1Rdf/\Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
\Cd19tm1(cre)Cgn/\Cd19+
\Ptpn11tm1Ckq/\Ptpn11+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:177285
\Cd28tm1Mak/\Cd28tm1Mak
\Rc3h1san/\Rc3h1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Cd44tm1Mak/\Cd44tm1Mak
\Trp53tm1Tyj/\Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J) 		increased lymphoma incidence J:76201
\Cdc20tm1.1Pzg/\Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:150421
\Cdk5rap2an/\Cdk5rap2an
\Tyrp1B-lt/\Tyrp1B-lt
(WBB6F1) 		increased histiocytic sarcoma incidence J:102334
\Cdk6tm1Phin/\Cdk6+
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:144975
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:70894
increased histiocytic sarcoma incidence J:70894
increased T cell derived lymphoma incidence J:70894
\Cdkn1btm1Mlf/\Cdkn1b+
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * CBA * FVB) 		increased T cell derived lymphoma incidence J:88323
\Cdkn1btm1Mlf/\Cdkn1b+
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Trp53tm1Brd/\Trp53tm1Brd
(involves: C3H * C57BL/6J * NIH) 		increased T cell derived lymphoma incidence J:87536
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased T cell derived lymphoma incidence J:87536
\Cdkn2atm1(GFP)Cjs/\Cdkn2atm1(GFP)Cjs
(involves: 129S1/Sv * C57BL/6) 		increased histiocytic sarcoma incidence J:87339
increased lymphoma incidence J:87339
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:44427
increased T cell derived lymphoma incidence J:44427
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Sclt1Tg(CAG-sb10)1Dla/0
\TgTn(sb-T2/Onc)68Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lymphoma incidence J:99991
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Sclt1Tg(CAG-sb10)1Dla/0
\TgTn(sb-T2/Onc)76Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lymphoma incidence J:99991
\Cdkn2atm1Nesh/\Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		increased small lymphocytic lymphoma incidence J:88365
\Cdkn2atm1Rdp/\Cdkn2a+
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:120065
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:53805
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		increased lymphoma incidence J:88365
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:131914
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Rnf2tm1Mvi/\Rnf2tm1Mvi
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL) 		increased lymphoma incidence J:130397
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:120065
\Cdkn2atm2.1Brn/\Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:71393
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:88365
increased small lymphocytic lymphoma incidence J:88365
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:131914
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased lymphoma incidence J:63299
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:63299
increased T cell derived lymphoma incidence J:63299
\Chd2Gt(RRBO46)Byg/\Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:146176
increased T cell derived lymphoma incidence J:146176
\Chek2tm1Mak/\Chek2tm1Mak
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Chfrtm1Jc/\Chfr+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:97428
\Chfrtm1Jc/\Chfrtm1Jc
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:97428
\Cks1btm1Sir/\Cks1b+
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
\Cks1btm1Sir/\Cks1btm1Sir
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
\Col1a1tm1(CAG-Mir22)Ppp/\Col1a1tm1(CAG-Mir22)Ppp
\Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:199366
\Col1a1tm3(tetO-GFP/RNAi:Apc)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:171191
increased T cell derived lymphoma incidence J:171191
\Col1a1tm4(tetO-GFP/RNAi:Apc)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:171191
increased T cell derived lymphoma incidence J:171191
\Cop1Gt(XR0653)1.1Wtsi/\Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:178271
increased histiocytic sarcoma incidence J:178271
increased T cell derived lymphoma incidence J:178271
\Crebbptm1Dli/\Crebbp+
(involves: 129S6/SvEvTac * C57BL/6) 		increased histiocytic sarcoma incidence J:60630
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:105505
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB) 		increased T cell derived lymphoma incidence J:88323
\Crkltm1Hkp/\Crkltm1Hkp
\Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
\Csf2tm1Dran/\Csf2tm1Dran
\Ifngtm1Ts/\Ifngtm1Ts
\Il3tm1Glli/\Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:83086
\Cul9tm1.2Yxi/\Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:170976
\Cul9tm1.2Yxi/\Cul9+
\Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
increased lymphoma incidence J:170976
\Cul9tm1.2Yxi/\Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:170976
\Cul9tm1.2Yxi/\Cul9tm1.2Yxi
\Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
increased lymphoma incidence J:170976
\Dclre1atm1Rleg/\Dclre1a+
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
increased lymphoma incidence J:102381
\Dclre1atm1Rleg/\Dclre1atm1Rleg
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
increased lymphoma incidence J:102381
\Dclre1atm1Rleg/\Dclre1atm1Rleg
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:102381
increased T cell derived lymphoma incidence J:102381
\Dcntm1Ioz/\Dcn+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased T cell derived lymphoma incidence J:53511
\Dcntm1Ioz/\Dcntm1Ioz
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased T cell derived lymphoma incidence J:53511
\Del(4Cdkn2a-Cdkn2b)1Brn/\+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:125189
\Del(4Cdkn2a-Cdkn2b)2Brn/\+
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:125189
\Del(4D4Mit190-D4Mit51)2Aam/\+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:121726
\Del(14Trim13-Dleu2)4Rdf/\+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
\Del(14Trim13-Dleu2)4Rdf/\Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
\Del(14Trim13-Rnaseh2b)6Rdf/\+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
\Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased B cell derived lymphoma incidence J:81054
\Dmtf1tm1Cjs/\Dmtf1+
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1+
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dna2tm1.1Lzhg/\Dna2+
(involves: 129S1/Sv) 		increased lymphoma incidence J:198831
\Dnmt1tm1(tetO-BCL2)Sjk/\Dnmt1+
\Tg(IghMyc)22Bri/0
\Tg(MMTVtTA)1Mam/0
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:93549
\Dnmt1tm1Jae/\Dnmt1+
\Mlh1tm1Lisk/\Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
\Dnmt1tm1Jae/\Dnmt1tm1Pwl
\Mlh1tm1Lisk/\Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
\Dnmt1tm1Pwl/\Dnmt1+
\Mlh1tm1Lisk/\Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
\Dok1tm1Yyam/\Dok1tm1Yyam
\Dok2tm1Yyam/\Dok2tm1Yyam
\Dok3tm1Brs/\Dok3tm1Brs
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:163407
\E2f1tm1Meg/\E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		increased T cell derived lymphoma incidence J:33100
\E2f1tm1Njd/\E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:33099
increased lymphoma incidence J:33099
\Eaf2tm1Zhow/\Eaf2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:145228
\Eaf2tm1Zhow/\Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased B cell derived lymphoma incidence J:145228
\Egr1tm1Jmi/\Egr1tm1Jmi
(involves: 129 * C57BL/6) 		increased T cell derived lymphoma incidence J:123870
\Emv30b/\Emv30b
\Prkdcscid/\Prkdcscid
(NOD.Cg-Emv30b Prkdcscid/Dvs) 		increased T cell derived lymphoma incidence J:29951
\Epm2aTg(TcraK,TcrbK)TG-BFlv/\Epm2a+
(involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J) 		increased T cell derived lymphoma incidence J:112696
\Esl1NFS/N/\Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
\Esl1SL/Kh/\Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
\Espl1Gt(XL058)Byg/\Espl1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		increased lymphoma incidence J:174926
\Ewsr1tm1(ERG)Thr/\Ewsr1+
\Rag1tm1(cre)Thr/\Rag1+
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:98679
\Exo1tm1Wed/\Exo1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:82426
\Exo1tm2Wed/\Exo1tm2Wed
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:198719
\Exo1tm3.1Wed/\Exo1tm3.1Wed
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:198719
\Exo1tm3.1Wed/\Exo1tm3.1Wed
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:198719
\Ezh2tm1.1Nesh/\Ezh2+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
\Ezh2tm1.1Nesh/\Ezh2tm1.1Nesh
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
\Fasldel1Hong/\Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6)) 		increased lymphoma incidence J:112563
\Faslgld/\Faslgld
(involves: C3H/HeJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
\Fasltm1.1Ast/\Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
\Fbxo4tm1.1Jadi/\Fbxo4+
(Not Specified) 		increased histiocytic sarcoma incidence J:178645
increased lymphoma incidence J:178645
\Fbxo4tm1.1Jadi/\Fbxo4tm1.1Jadi
(Not Specified) 		increased histiocytic sarcoma incidence J:178645
increased lymphoma incidence J:178645
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai
\Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:137138
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:128523
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:128523
increased T cell derived lymphoma incidence J:128523
\Fdxrtm1Xch/\Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased B cell derived lymphoma incidence J:244082
increased lymphoma incidence J:244082
increased T cell derived lymphoma incidence J:244082
\Fen1tm1Rak/\Fen1+
(involves: 129/Sv * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:77962
\Fen1tm2Klng/\Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:138901
\Fhittm1Tko/\Fhit+
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
increased lymphoma incidence J:93269
\Fhittm1Tko/\Fhittm1Tko
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
increased lymphoma incidence J:93269
\FlcnGt(RRX115)Byg/\Flcn+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:147582
\Flt3tm2.1Dosm/\Flt3+
(B6.129(C)-Flt3tm2.1Dosm) 		increased B cell derived lymphoma incidence J:205200
increased histiocytic sarcoma incidence J:205200
\Foc1NFS/N/\Foc1NFS/N
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
\Foxo1tm1Rdp/\Foxo1tm1Rdp
\Foxo3tm1Rdp/\Foxo3tm1Rdp
\Foxo4tm1Rdp/\Foxo4tm1Rdp
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased T cell derived lymphoma incidence J:118179
\Foxq1sa/\Foxq1sa
\Lystbg/\Lystbg
(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl) 		increased lymphoma incidence J:5311
\Gpx7tm1Whle/\Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:193993
\Grb2tm1Paw/\Grb2+
\Ptentm1Mak/\Pten+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:93530
\Grb2tm1Paw/\Grb2+
\Ptentm2Mak/\Ptentm2Mak
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:93530
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
\Tacc3tm1.1Tno/\Tacc3+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
\Tacc3tm1.1Tno/\Tacc3tm1.2Tno
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:130367
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:167612
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
\Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/\Gt(ROSA)26Sor+
\Ptentm1.1Hwu/\Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased lymphoma incidence J:170965
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:160931
\Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu/\Gt(ROSA)26Sor+
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu Tg(Lck-cre)548Jxm) 		increased T cell derived lymphoma incidence J:185287
\Gt(ROSA)26Sortm1(pb)Peli/\Gt(ROSA)26Sor+
\TgTn(pb-sb-ATP2)H27Brd/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:166063
\Gt(ROSA)26Sortm1(pb)Peli/\Gt(ROSA)26Sor+
\TgTn(pb-sb-ATP2)H32Brd/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:166063
\Gt(ROSA)26Sortm1(pb)Peli/\Gt(ROSA)26Sor+
\TgTn(pb-sb-ATP2)S1Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased lymphoma incidence J:166063
\Gt(ROSA)26Sortm1(pb)Peli/\Gt(ROSA)26Sor+
\TgTn(pb-sb-ATP2)S2Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased lymphoma incidence J:166063
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\Tg(MMTV-cre)#Tfln/0
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased lymphoma incidence J:170898
increased T cell derived lymphoma incidence J:170898
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased lymphoma incidence J:170898
increased T cell derived lymphoma incidence J:170898
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:166283
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/\Hprt1+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:166283
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
increased lymphoma incidence J:153656
increased T cell derived lymphoma incidence J:153656
\Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J) 		increased lymphoma incidence J:163919
\Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		increased B cell derived lymphoma incidence J:185598
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
\Tg(GFP/KRAS2/ALPP)1Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:127226
\Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:137122
\Gt(ROSA)26Sortm2.1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J) 		increased T cell derived lymphoma incidence J:153656
\Gt(ROSA)26Sortm4(CAG-hsb5)Nki/\Gt(ROSA)26Sor+
\Npm1tm1Gsva/\Npm1+
\TgTn(pb-sb-GrOnc)#aGsva/0
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
increased lymphoma incidence J:172071
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:167612
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:191824
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ) 		increased B cell derived lymphoma incidence J:181546
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:181546
\Gt(ROSA)26Sortm18(Zeb2)Jhai/\Gt(ROSA)26Sor+
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\Gt(ROSA)26Sortm18(Zeb2)Jhai/\Gt(ROSA)26Sortm18(Zeb2)Jhai
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\H2u/\H2u
\Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J) 		increased T cell derived lymphoma incidence J:92992
\H2u/\H2u
\Tg(TCRA)B1Jg/0
\Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg) 		increased T cell derived lymphoma incidence J:92992
\H2axtm1Fwa/\H2ax+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
increased lymphoma incidence J:84879
increased T cell derived lymphoma incidence J:84879
\H2axtm1Fwa/\H2axtm1Fwa
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:84879
\H2axtm1Fwa/\H2axtm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
increased T cell derived lymphoma incidence J:84879
\H2axtm1Nus/\H2axtm1Nus
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:86590
\Hace1tm1Pngr/\Hace1tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:125183
\Hat1tm1.1Mrpa/\Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		increased histiocytic sarcoma incidence J:296531
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2tm1.1Shmc
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:194769
\Hephl1cw/\Hephl1cw
(CWD/LeJ) 		increased B cell derived lymphoma incidence J:24875
increased lymphoma incidence J:24875
\Hic1tm1Sbb/\Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:81448
\Hip1tm4Tsr/\Hip1+
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:151974
\Hmga1tm1Afus/\Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:106702
\Hrhr/\Hrhr
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:79734
\Hrhr/\Hrhr
\Msh2tm1Htr/\Msh2tm1Htr
\Xpatm1Tnka/\Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:79734
\Icostm1Flv/\Icostm1Flv
\Rc3h1san/\Rc3h1+
(involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Id1tm1Zhu/\Id1tm1Zhu
\Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased T cell derived lymphoma incidence J:44278
\Ifngtm1Ts/\Ifngtm1Ts
(B6.129S7-Ifngtm1Ts) 		increased lymphoma incidence J:77491
increased T cell derived lymphoma incidence J:77491
\Ifngtm1Ts/\Ifngtm1Ts
\Prf1tm1Sdz/\Prf1tm1Sdz
(C.Cg-Prf1tm1Sdz Ifngtm1Ts) 		increased B cell derived lymphoma incidence J:77491
increased lymphoma incidence J:77491
\Igh-Vtm1(Igh-Vx24)Hmb/\Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:54380
increased T cell derived lymphoma incidence J:54380
\Ightm1(Myc)Janz/\Igh+
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:160845, J:96785
\Ightm1(Myc)Janz/\Igh+
\Mdm4tm1.1Wahl/\Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:150341
increased lymphoma incidence J:150341
\Ightm1(Myc)Janz/\Igh+
\Tg(Emu-FGFR3)A5Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
\Ightm1(Myc)Janz/\Igh+
\Tg(Emu-FGFR3)D3Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
\Ightm1(PAX5)Mbu/\Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
\Ightm1(PAX5)Mbu/\Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
\Ighatm1(Myc)Janz/\Igha+
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:90901
\Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:98937
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		increased lymphoma incidence J:80859
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(IghMyc)22Bri/0
(involves: 129S2/SvPas * C57BL * SJL) 		increased lymphoma incidence J:187318
\Ikzf1plstc/\Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		increased T cell derived lymphoma incidence J:84569
\Ikzf1tm1(Pax5)Mbu/\Ikzf1+
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:118111
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
\Ikzf1tm2.1Smale/\Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale) 		increased lymphoma incidence J:208211
\Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu
\Il7rtm1.1(icre)Hrr/\Il7r+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:209928
\Ikzf1tm3Kge/\Ikzf1tm3Kge
\Tg(CD2-icre)4Kio/?
(involves: C57BL/10 * CBA/Ca) 		increased T cell derived lymphoma incidence J:209927
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:50626
\Ing1Gt(OST206270)Lex/\Ing1+
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
\Ing1Gt(OST206270)Lex/\Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
\Ing1tm1Avg/\Ing1tm1Avg
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:105658
\Ing2tm1.1Ccha/\Ing2tm1.1Ccha
(involves: 129 * C57BL/6J * FVB/N) 		increased histiocytic sarcoma incidence J:167311
\Ino80tm1.1Schg/\Ino80+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:221224
\Inpp5dm1Anu/\Inpp5dm1Anu
(C57BL/6JAnu-Inpp5dm1Anu) 		increased B cell derived lymphoma incidence J:104190
\Irf1tm1Mak/\Irf1tm1Mak
(B6.129S2-Irf1tm1Mak/J) 		increased lymphoma incidence J:91927
\Irf1tm1Mak/\Irf1tm1Mak
\Trp53tm1Sia/\Trp53tm1Sia
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased lymphoma incidence J:55418
\Irf8tm1Hor/\Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		increased lymphoma incidence J:36038
\Is(14)1Rdf \Is(14)2Rdf/\Del(14Trim13-Dleu2)4Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
\Is(14)1Rdf \Is(14)5Rdf/\Del(14Trim13-Rnaseh2b)6Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
\Is(14)1Rdf/\Is(14)1Rdf
\Is(14)5Rdf/\Is(14)5Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
\Kat5tm1Jwl/\Kat5+
\Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
\Kat5tm1Jwl/\Kat5+
\Tg(IghMyc)22Bri/0
\Trp53tm1Tyj/\Trp53+
(involves: 129 * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
\Klf14em1Cgw/\Klf14em1Cgw
(C57BL/6J-Klf14em1Cgw) 		increased lymphoma incidence J:227200
\Klrk1tm1Dhr/\Klrk1tm1Dhr
\Tg(IghMyc)22Bri/?
(involves: C57BL/6 * CD-1) 		increased B cell derived lymphoma incidence J:134509
\Kmt2atm1(AFF1)Ksy/\Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
\Kmt2atm1Thr/\Kmt2a+
\Mllt3tm2Thr/\Mllt3+
\Tg(Lck-cre)1Thr/?
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:100794
\Kmt2atm2(MLLT3)Thr/\Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
\Kmt2dtm1.1Kaig/\Kmt2d+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Ighg1tm1(cre)Cgn/\Ighg1+
\Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas) 		increased lymphoma incidence J:129627
increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
\Trp53tm1Glo/\Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:129627
\Krastm2Tyj/\Kras+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
\Mir21atm1.1Eno/\Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:164198
\Krastm3Tyj/\Krastm3Tyj
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:237900
\Krastm4Tyj/\Kras+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		increased lymphoblastic lymphoma incidence J:88163
\Krastm4Tyj/\Kras+
\Trp53tm2Tyj/\Trp53+
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:98936
\Lig1tm3Dwm/\Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:77902
\Lig4tm1Fwa/\Lig4tm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased lymphoma incidence J:63078
\Lig4tm1Icrf/\Lig4tm1Icrf
\Trp53tm1Tyj/\Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)) 		increased B cell derived lymphoma incidence J:111068
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:157574
\ll/\ll
X/\Yaa
(BXSB/MpJScr-ll) 		increased lymphoma incidence J:10973
increased T cell derived lymphoma incidence J:10973
\llaSL/Kh/\llaSL/Kh
(involves: AKR/JMs * SL/Kh) 		increased lymphoma incidence J:41197, J:33016
\Lpoem1Zlu/\Lpoem1Zlu
(involves: C57BL/6 * SJL) 		increased histiocytic sarcoma incidence J:307289
increased lymphoma incidence J:307289
\LyarGt(RRG292)Byg/\LyarGt(RRG292)Byg
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:263530
\LyrBALB/cHeA/\LyrBALB/cHeA
(involves: BALB/cHeA * STS/A) 		increased lymphoma incidence J:10558
\Lzts1tm1Cro/\Lzts1+
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:119989
\Lzts1tm1Cro/\Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:119989
\Mapkapk5tm1Pqs/\Mapkapk5+
\Tg(SV40-NRAS*G12D)1Sco/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:117893
\Mapkapk5tm1Pqs/\Mapkapk5tm1Pqs
\Tg(SV40-NRAS*G12D)1Sco/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:117893
\Mapttm1(EGFP)Klt/\Mapttm1(EGFP)Klt
\Tg(MAPT)8cPdav/?
(involves: 129S4/SvJae * C57BL/6 * Swiss Webster) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
\MclrRF/J/\MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
\MclrSWR/J/\MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
\Mcm2Gt(AB0178)Wtsi/\Mcm2+
\Mcm4chaos3/\Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:165667
\Mcm3Gt(RRR002)Byg/\Mcm3+
\Mcm4chaos3/\Mcm4chaos3
\Mcm6Gt(YHD248)Byg/\Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased lymphoma incidence J:165667
\Mcm3Gt(RRR002)Byg/\Mcm3+
\Mcm4chaos3/\Mcm4Gt(RRE056)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased lymphoma incidence J:165667
\Mcm3tm1.1Geno/\Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:227638
\Mcm3tm1.2Geno/\Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:227638
\Mcm4chaos3/\Mcm4chaos3
(involves: C57BL/6J) 		increased lymphoma incidence J:165667
increased T cell derived lymphoma incidence J:165667
\Mdm2tm1.1Ypz/\Mdm2tm1.1Ypz
\Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri) 		increased lymphoma incidence J:164200
\Mdm2tm2.1Snj/\Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:189297
increased T cell derived lymphoma incidence J:189297
\Mdm2tm3.1Glo/\Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo) 		increased lymphoma incidence J:164201
\Mdm2tm3.1Glo/\Mdm2tm3.1Glo
\Trp53tm3.1Glo/\Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased histiocytic sarcoma incidence J:164201
increased lymphoma incidence J:164201
\Mdm2tm4.1Glo/\Mdm2tm4.1Glo
\Trp53tm3.1Glo/\Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased histiocytic sarcoma incidence J:164201
increased lymphoma incidence J:164201
\Mdm4tm1Glo/\Mdm4+
\Tg(IghMyc)22Bri/0
(involves: 129S6/SvEvTac * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:123661
\Mef2btm2Rdf/\Mef2b+
\Tg(BCL2/IGH)M23Tjd/0
\Tg(Cr2-cre)3Cgn/0
(involves: C3H/He * C57BL/6) 		increased follicular lymphoma incidence J:265465
increased lymphoma incidence J:265465
\Mef2btm2Rdf/\Mef2b+
\Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:265465
\Mettm1Gvw/\Met+
(involves: 129 * C57BL/6J) 		increased histiocytic sarcoma incidence J:94722
increased lymphoma incidence J:94722
\Mettm2Gvw/\Met+
(involves: 129 * C57BL/6J) 		increased histiocytic sarcoma incidence J:94722
increased lymphoma incidence J:94722
\Mettm4Gvw/\Met+
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:94722
\Mgmttm1Mse/\Mgmttm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mgmttm1Mse/\Mgmttm1Mse
\Mlh1tm1Mse/\Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173230
increased follicular lymphoma incidence J:173230
increased T cell derived lymphoma incidence J:173230
\Mir146tm2.1Bal/\Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased follicular lymphoma incidence J:173671
\Mirc1tm2.1Aven/\Mirc1tm2.1Aven
\Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:223213
\Mirc30tm1.2Rdf/\Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
\Mlh1tm1Lisk/\Mlh1tm1Lisk
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:34291
\Mlh1tm1Lisk/\Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
\Mlh1tm1Mse/\Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mlh1tm1Rak/\Mlh1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:53451
increased T cell derived lymphoma incidence J:53451
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:98929, J:53451
increased lymphoma incidence J:53451
increased T cell derived lymphoma incidence J:53451
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:133352
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased lymphoma incidence J:153684
increased T cell derived lymphoma incidence J:153684
\Mlh1tm1Wed/\Mlh1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:133352
\Mre11atm1Jpt/\Mre11a+
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Mre11atm1Jpt/\Mre11atm1Jpt
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Msh2tm1Htr/\Msh2tm1Htr
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		increased T cell derived lymphoma incidence J:27469
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:45433
increased T cell derived lymphoma incidence J:45433
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd * FVB) 		increased lymphoma incidence J:45433
increased T cell derived lymphoma incidence J:45433
\Msh2tm1Htr/\Msh2tm1Htr
\Smug1tm1a(EUCOMM)Hmgu/\Smug1tm1a(EUCOMM)Hmgu
\Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:197809
\Msh2tm1Htr/\Msh2tm1Htr
\Smug1tm1a(EUCOMM)Hmgu/\Smug1tm1a(EUCOMM)Hmgu
\Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:197809
\Msh2tm1Mak/\Msh2+
\Mutyhtm1Jhmi/\Mutyhtm1Jhmi
\Ogg1tm1Tld/\Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
\Msh2tm1Mak/\Msh2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:28397
\Msh2tm1Mak/\Msh2tm1Mak
\Mutyhtm1Jhmi/\Mutyhtm1Jhmi
\Ogg1tm1Tld/\Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
\Msh2tm1Rak/\Msh2+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:64667
\Msh2tm1Rak/\Msh2tm1Rak
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:64667
\Msh2tm1Rak/\Msh2tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:98929
\Msh2tm1Wed/\Msh2tm1Wed
(involves: C57BL/6) 		increased lymphoma incidence J:86278
\Msh2tm1Wed/\Msh2tm1Wed
(involves: 129 * C57BL/6 * SJL) 		increased lymphoma incidence J:88092
\Msh2tm1Whl/\Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
\Msh2tm1Whl/\Msh2tm1Whl
\Rb1tm1Brd/\Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
\Msh2tm2.1Rak/\Msh2tm2.1Rak
\Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:161577
\Msh2tm2.2Rak/\Msh2tm2.2Rak
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:161577
\Msh3tm1Htr/\Msh3tm1Htr
\Msh6tm1Htr/\Msh6tm1Htr
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:59561
\Msh3tm1Rak/\Msh3tm1Rak
\Msh6tm1Rak/\Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:60604
\Msh6tm1Htr/\Msh6tm1Htr
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:59561
\Msh6tm1Rak/\Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:44428
\Msh6tm1Wed/\Msh6+
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:92555
\Msh6tm1Wed/\Msh6tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:92555
\Msmr1SL/Kh/\Msmr1SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased lymphoma incidence J:34941
\Msmr1SL/Kh/\Msmr1SL/Kh
\Msmr2SL/Kh/\Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased B cell derived lymphoma incidence J:34941
\Msmr2SL/Kh/\Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased lymphoma incidence J:34941
\Mtbptm1Glo/\Mtbp+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:135509
\Mtf1Thyls-BALB/c/\Mtf1Thyls-BALB/c
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:71358
\Mtf1Thyls-BALB/c/\Mtf1Thyls-MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:85264, J:71358
\Mtss1Gt(CSC156)Byg/\Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		increased B cell derived lymphoma incidence J:186118
\Mtus1Gt(RRA048)Byg/\Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:212144
\Mus81tm1Raz/\Mus81+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:91570
\Mus81tm1Raz/\Mus81tm1Raz
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:91570
increased lymphoma incidence J:91570
\Mutyhtm1Jhmi/\Mutyhtm1Jhmi
\Ogg1tm1Tld/\Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
\Myctm1Lbox/\Myc+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
\Myctm1Lbox/\Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
\Myh14tm2Rsad/\Myh14+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:171110
\Myh14tm2Rsad/\Myh14tm2Rsad
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:171110
\Nabp2tm1.1Kkha/\Nabp2tm1.1Kkha
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:195140
increased T cell derived lymphoma incidence J:195140
\Nabp2tm1Schg/\Nabp2tm1Schg
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:228558
\Nbnem3Jpt/\Nbnem3Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:251434
\Nbnem4Jpt/\Nbnem4Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:251434
\Nbnem7Jpt/\Nbntm2Zqw
\Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:277750
\Nbntm1Jpt/\Nbntm1Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:75956
\Nbntm1Xu/\Nbntm1Xu
(Not Specified) 		increased T cell derived lymphoma incidence J:75272
\Nbntm1Zqw/\Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:86563
increased lymphoma incidence J:86563
increased T cell derived lymphoma incidence J:86563
\Nbntm2Zqw/\Nbntm2Zqw
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Nes-cre)1Wme/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased lymphoma incidence J:98316
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:109522
increased lymphoma incidence J:109522
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rragatm2Dmsa/\Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:213516
\Ndrg2tm1Kmori/\Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
\Ndrg2tm1Kmori/\Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
\Nf1tm1Fcr/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:58877
\Nf1tm1Fcr/\Nf1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:58877
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:18542
\Nf1tm1Tyj/\Nf1+
\Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:217077
\Nf1tm1Tyj/\Nf1+
\Suz12Gt(Betageo)1Khe/\Suz12+
\Trp53tm1Tyj/\Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:217077
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:228258, J:217077
\Nf2tm1Tyj/\Nf2+
(either: (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) or (involves: 129S2/SvPas * C57BL/6J)) 		increased lymphoma incidence J:47282
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:132943
\Nhej1tm1Fwa/\Nhej1tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129) 		increased B cell derived lymphoma incidence J:138774
increased T cell derived lymphoma incidence J:138774
\Nme1tm1Jyd/\Nme1tm1Jyd
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:109190
\Npm1tm1Gsva/\Npm1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
\Npm1tm1Ppp/\Npm1+
\Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:101494
\Nrbp1tm1.1Dja/\Nrbp1tm1.1Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		increased lymphoma incidence J:184685
\Nrbp1tm1.1Dja/\Nrbp1tm1.2Dja
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:184685
\Nsmce2Gt(AA0032)Wtsi/\Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased histiocytic sarcoma incidence J:227197
increased lymphoma incidence J:227197
\Pcbp4Gt(D136D11)Wrst/\Pcbp4+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
\Pcbp4Gt(D136D11)Wrst/\Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
\Pdcd4tm1Yhcn/\Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		increased B cell derived lymphoma incidence J:120583
\Per2tm1Brd/\Per2tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:79456
\Pigatm1Bsl/Y
\Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
\Pigatm1Bsl/\Piga+
\Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
\Pinx1tm1.1Kplu/\Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased histiocytic sarcoma incidence J:171997
increased lymphoma incidence J:171997
\Pinx1tm1.1Kplu/\Pinx1+
\Trp53tm1Brd/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:171997
\Pinx1tm1.1Kplu/\Pinx1+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:171997
\Pknox1tm1Ngc/\Pknox1+
\Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased B cell derived lymphoma incidence J:192251
\Plcg2tm1Jni/\Plcg2tm1Jni
\Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:117023
increased lymphoma incidence J:117023
\Plk1Gt(RRR358)Byg/\Plk1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:142593
\Pmltm1.1Ews/\Pmltm1.1Ews
(involves: 129 * 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:262172
increased T cell derived lymphoma incidence J:262172
\Pmltm1Ppp/\Pml+
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504
increased T cell derived lymphoma incidence J:317504
\Pmltm1Ppp/\Pmltm1Ppp
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:46381
\Pmltm1Ppp/\Pmltm1Ppp
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504
increased T cell derived lymphoma incidence J:317504
\Pms2tm1.1Wed/\Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased B cell derived lymphoma incidence J:162378
increased lymphoma incidence J:162378
increased T cell derived lymphoma incidence J:162378
\Pms2tm1Lisk/\Pms2tm1Lisk
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:27389
\Pms2tm1Lisk/\Pms2tm1Lisk
(involves: 129S2/SvPas) 		increased B cell derived lymphoma incidence J:162378
increased lymphoma incidence J:125218
\Pms2tm1Lisk/\Pms2tm1Lisk
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		increased lymphoma incidence J:125218
\Pold1tm1.1Bdp/\Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp) 		increased lymphoma incidence J:153684
increased T cell derived lymphoma incidence J:153684
\Pold1tm1.1Bdp/\Pold1tm1.1Bdp
\Poletm1.1Bdp/\Poletm1.1Bdp
(B6.129-Poletm1.1Bdp Pold1tm1.1Bdp) 		increased T cell derived lymphoma incidence J:153684
\Pold1tm1Bdp/\Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:80306, J:100685
increased T cell derived lymphoma incidence J:100685
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N) 		increased lymphoma incidence J:261973
increased T cell derived lymphoma incidence J:261973
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
\Trp53tm1Brd/\Trp53+
(involves: C57BL/6J * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:261973
\Poletm1.1Bdp/\Poletm1.1Bdp
(B6.129-Poletm1.1Bdp) 		increased histiocytic sarcoma incidence J:153684
increased lymphoma incidence J:153684
\Polgtm1Jiha/\Polg+
(involves: C57BL/6JJcl) 		increased B cell derived lymphoma incidence J:199416
\Ppp5ctm1a(EUCOMM)Wtsi/\Ppp5ctm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:213427
\Prdm2tm1Shg/\Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
increased lymphoma incidence J:71406
\Prdm2tm1Shg/\Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
increased lymphoma incidence J:71406
\Prdm11tm1.1Ahl/\Prdm11tm1.1Ahl
\Tg(IghMyc)22Bri/0
(B6.Cg-Prdm11tm1.1Ahl Tg(IghMyc)22Bri) 		increased B cell derived lymphoma incidence J:221379
\Prdx1tm1Rave/\Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased histiocytic sarcoma incidence J:84677
increased lymphoma incidence J:84677
\Prdx1tm1Rave/\Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased B cell derived lymphoma incidence J:84677
increased histiocytic sarcoma incidence J:84677
increased lymphoma incidence J:84677
increased T cell derived lymphoma incidence J:84677
\Prf1tm1Sdz/\Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz) 		increased B cell derived lymphoma incidence J:77491
increased lymphoma incidence J:77491
\Prf1tm1Sdz/\Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		increased lymphoma incidence J:77491
increased T cell derived lymphoma incidence J:77491
\Prkdcscid/\Prkdcscid
(C.BKa-Prkdcscid) 		increased T cell derived lymphoma incidence J:6958
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid) 		increased T cell derived lymphoma incidence J:109833, J:22026
\Prkdctm1Gcl/\Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:53765
\Psmb9tm1Stl/\Psmb9tm1Stl
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:67509
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
\Ptentm1.1Gle/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
\Ptentm1.1Hwu/\Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased lymphoma incidence J:170965
\Ptentm1.2Mwst/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
\Ptentm1Mak/\Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:63478
increased T cell derived lymphoma incidence J:50437
\Ptentm1Mak/\Pten+
(B6.129P2-Ptentm1Mak) 		increased lymphoma incidence J:93530
\Ptentm1Rps/\Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:53065
\Ptentm2.1Gle/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
\Ptentm2Mak/\Ptentm2Mak
\Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:143082
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:177285
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:177285
increased lymphoblastic lymphoma incidence J:177285
\Ptprctm1Holm/\Ptprctm1Holm
\Tg(Lck*F505)2964Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
\Ptprctm1Holm/\Ptprctm1Holm
\Tg(Lck*F505)3073Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
\Puf60tm1.1Kmtsu/\Puf60+
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
\Rad50tm1Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Rad50tm2Jpt/\Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		increased T cell derived lymphoma incidence J:78820
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
\Rad50tm2Jpt/\Rad50tm2Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:78820
\Rag1tm1Jsek/\Rag1tm1Jsek
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:146912
\Rag1tm1Mom/\Rag1+
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1+
\Tg(LPV-TAg1135)11Tvd/0
\Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
\Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz) 		increased T cell derived lymphoma incidence J:109843
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(LPV-TAg1135)11Tvd/0
\Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased T cell derived lymphoma incidence J:141515
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased T cell derived lymphoma incidence J:141515
\Rag2tm1.1Desi/\Rag2tm1.1Desi
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:168974
increased T cell derived lymphoma incidence J:168974
\Rag2tm1.1Mss/\Rag2tm1.1Mss
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:170462
increased T cell derived lymphoma incidence J:170462
\Rag2tm1Fwa/\Rag2+
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased T cell derived lymphoma incidence J:235890
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm2.1Desi/\Rag2tm2.1Desi
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:168974
\Rarres1tm1.2Mhl/\Rarres1+
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
\Rarres1tm1.2Mhl/\Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
\Rarres1tm1d(KOMP)Wtsi/\Rarres1+
(involves: C57BL/6N) 		increased follicular lymphoma incidence J:324270
\Rasal2Gt(463C12)Cmhd/\Rasal2Gt(463C12)Cmhd
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased lymphoma incidence J:202603
\Rassf1tm1.2Brd/\Rassf1tm1.2Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:101369
\Rassf1tm1Gpp/\Rassf1tm1Gpp
(involves: 129S1/SvImJ * C57BL/6) 		increased B cell derived lymphoma incidence J:95683
\Rassf5tm1Kina/\Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased B cell derived lymphoma incidence J:168749
\Rb1tm1.1Jyjw/\Rb1tm1.1Jyjw
\Trp53tm1Tyj/\Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased lymphoma incidence J:102483
\Rb1tm3Fad/\Rb1tm3Fad
(involves: 129S1/Sv * 129X1/SvJ) 		increased lymphoma incidence J:249124
\Rbbp8tm1Whl/\Rbbp8+
(Not Specified) 		increased lymphoma incidence J:97648
\Rbm38tm1.1Xch/\Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		increased lymphoma incidence J:216929
\Rbm38tm1.1Xch/\Rbm38tm1.1Xch
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		increased lymphoma incidence J:216929
\Rc3h1san/\Rc3h1+
(involves: C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Rcbtb2tm1.1Xyw/\Rcbtb2+
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
increased lymphoma incidence J:282928
\Rcbtb2tm1.1Xyw/\Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
increased lymphoma incidence J:282928
\Recql4tm1Glu/\Recql4tm1Glu
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:97101
\Rev3ltm1Rwd/\Rev3ltm2.1Rwd
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:158922
\Rgsc142/\Rgsc142+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased T cell derived lymphoma incidence J:133634
\Rint1tm1Whl/\Rint1+
(Not Specified) 		increased lymphoma incidence J:122805
\Rnf8Gt(AS0574)Wtsi/\Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:161240
increased T cell derived lymphoma incidence J:161240
\Rnf8Gt(RRR260)Byg/\Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:161240
increased T cell derived lymphoma incidence J:161240
\Rnf168Gt(156B6)Cmhd/\Rnf168Gt(156B6)Cmhd
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
\Rnf168Gt(405F11)Cmhd/\Rnf168Gt(405F11)Cmhd
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
\Robo1tm1Phr/\Robo1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:93666
\Rpa1tm1Wed/\Rpa1+
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:99303
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased B cell derived lymphoma incidence J:223276
increased T cell derived lymphoma incidence J:223276
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:223276
\Rr149356tm1Che/\Rr149356tm1Che
\Tcrdtm1Mom/\Tcrdtm1Mom
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
\Rr149356tm1Che/\Rr149356tm1Che
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
\Rtel1tm2.1Hdin/\Rtel1tm2.1Hdin
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:202812
\Runx1tm1(RUNX1)Gcg/\Runx1tm1(RUNX1)Gcg
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:106800
\Runx1tm1Spe/\Runx1+
(either: (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/Ca) or (involves: 129S4/SvJae * C57BL/6 * CBA/Ca)) 		increased T cell derived lymphoma incidence J:80829
\Runx1tm2Buch/\Runx1tm2Buch
\Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:105709
increased T cell derived lymphoma incidence J:105709
\Runx1tm3Dow/\Runx1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:77129
\S1pr2tm1Ajml/\S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:154439
\S1pr2tm1Ajml/\S1pr2tm1Ajml
(129S5/SvEvBrd-S1pr2tm1Ajml) 		increased B cell derived lymphoma incidence J:154439
\S100a4tm1Amba/\S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased lymphoma incidence J:89563
\Sav1tm1Dlim/\Sav1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased lymphoma incidence J:160325
\Sirt1tm1.1Cxd/\Sirt1+
\Trp53tm1Brd/\Trp53+
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)) 		increased lymphoma incidence J:140089
\Sirt2tm1.1Cxd/\Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased B cell derived lymphoma incidence J:177486
\Skitm1Cco/\Ski+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:73349
\Skiltm1Sis/\Skil+
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:62174
increased T cell derived lymphoma incidence J:62174
\Slc29a3tm1Lex/\Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased histiocytic sarcoma incidence J:179286
\Slc33a1tm1.1Lpu/\Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:211266
\Smarcb1tm1Sho/\Smarcb1tm3Sho
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA) 		increased lymphoma incidence J:80224
increased T cell derived lymphoma incidence J:80224
\Smg1Gt(AG0297)Wtsi/\Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:193626
increased lymphoma incidence J:193626
\Smurf2Gt(RRA098)Byg/\Smurf2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:189320
\Smurf2Gt(RRA098)Byg/\Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:189320, J:245679
increased lymphoma incidence J:189320
\Sod2tm1Cje/\Sod2+
(B6.Cg-Sod2tm1Cje/Mmmh) 		increased lymphoma incidence J:87514
\Spi1tm1.1Dgt/\Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:90331
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:106040
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:90331
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac) 		increased lymphoma incidence J:166879
\Srpxtm1Hzi/\Srpx+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:119999
\Srpxtm1Hzi/\Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:119999
increased T cell derived lymphoma incidence J:119999
\Ssbp2tm1Lana/\Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		increased B cell derived lymphoma incidence J:162035
increased lymphoma incidence J:162035
\Ssbp2tm1Lana/\Ssbp2tm1Lana
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:162035
\Stag1Gt(P099A04)Wrst/\Stag1+
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:184720
increased lymphoma incidence J:184720
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased histiocytic sarcoma incidence J:153945
\Stk11tm1.1Mlfr/\Stk11+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:104347
\Stk38tm1Hem/\Stk38+
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
\Stk38tm1Hem/\Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
\SufuGt(XB699)Byg/\Sufu+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:125534
\Suv39h1tm1Jnw/\Suv39h1+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h1tm1Jnw/\Suv39h1+
\Suv39h2tm1Jnw/\Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h1tm1Jnw/\Suv39h1+
\Suv39h2tm1Jnw/\Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h1tm1Jnw/\Suv39h1tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h1tm1Jnw/\Suv39h1tm1Jnw
\Suv39h2tm1Jnw/\Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h2tm1Jnw/\Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suv39h2tm1Jnw/\Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
\Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd) 		increased histiocytic sarcoma incidence J:217077
\Tbrg1tm1a(KOMP)Wtsi/\Tbrg1tm1a(KOMP)Wtsi
(C57BL/6N-Tbrg1tm1a(KOMP)Wtsi) 		increased B cell derived lymphoma incidence J:225146
\Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S4/SvJaeSor * C57BL/6) 		increased T cell derived lymphoma incidence J:44278
\Tcf3tm2Wein/\Tcf3tm2Wein
(Not Specified) 		increased T cell derived lymphoma incidence J:47671
\Terctm1Rdp/\Terctm1Rdp
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		increased lymphoma incidence J:125218
\Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased B cell derived lymphoma incidence J:89878
\Tg(ACTB-Eif4e)#Ppp/0
\Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased lymphoma incidence J:89878
\Tg(BCL2)22Wehi/0
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi) 		increased lymphoma incidence J:69571
\Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased T cell derived lymphoma incidence J:93111
\Tg(BCL2/IGH)#Jcre/0
\Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J) 		increased small lymphocytic lymphoma incidence J:94116
\Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:89786
\Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
\Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:181238
\Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci) 		increased T cell derived lymphoma incidence J:93665
\Tg(Cd4-NPM/ALK)N1Ingh/0
(either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster)) 		increased lymphoblastic lymphoma incidence J:82127
\Tg(Cd4-NPM/ALK)N1Ingh/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		increased T cell derived lymphoma incidence J:235890
\Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:79703
\Tg(CMV-tTA)3Bjd/0
\Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased histiocytic sarcoma incidence J:94953
increased lymphoma incidence J:94953
\Tg(Emu-Pim1)64aBrn/0
(involves: C57BL/6LiA * CBA) 		increased lymphoma incidence J:79624
increased T cell derived lymphoma incidence J:79624
\Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		increased B cell derived lymphoma incidence J:117018
\Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:237420
increased histiocytic sarcoma incidence J:237420
increased splenic marginal zone lymphoma incidence J:237420
\Tg(EmuSR-tTa)83Bop/0
\Tg(IghMyc)22Bri/0
\Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: C57BL * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:123006
\Tg(EmuSR-tTa)83Bop/\Tg(EmuSR-tTa)83Bop
\Tg(tetO-NPM1/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
\Tg(EmuSR-tTa)83Bop/\Tg(EmuSR-tTa)83Bop
\Tg(tetO-TPM3/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
\Tg(H2-K-Hmga1)#Lmsr/0
(involves: C57BL/6 * SJL) 		increased lymphoma incidence J:90252, J:121308
\Tg(H2-L-IL6)46Kish/\Tg(H2-L-IL6)46Kish
(C.B6-Tg(H2-L-IL6)46Kish) 		increased B cell derived lymphoma incidence J:74377
increased follicular lymphoma incidence J:74377
\Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6) 		increased lymphoma incidence J:64968
\Tg(HRAS)7Mok/?
(involves: C57BL/6) 		increased lymphoma incidence J:64968
\Tg(Igh*-Mir125b-1)5Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
increased lymphoma incidence J:178816
\Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
increased lymphoma incidence J:178816
increased T cell derived lymphoma incidence J:178816
\Tg(Igh-HOX11)11Idd/0
(CD-1) 		increased B cell derived lymphoma incidence J:52782
\Tg(Igh-Maf)68Staka/0
(C57BL/6-Tg(Igh-Maf)68Staka) 		increased lymphoma incidence J:168074
\Tg(Igh-Maf)524Staka/0
(involves: C57BL/6 * C57BL/6J * DBA/2) 		increased lymphoma incidence J:168074
\Tg(Igh-Mir155)8Cro/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:109591
increased lymphoblastic lymphoma incidence J:109591
\Tg(Igh-Pim1)1Brn/0
(involves: C57BL/6LiA * CBA) 		increased lymphoma incidence J:79624
increased T cell derived lymphoma incidence J:79624
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117, J:78177
increased lymphoma incidence J:78177, J:223213
\Tg(IghMyc)22Bri/0
(B6.Cg-Tg(IghMyc)22Bri/J) 		increased B cell derived lymphoma incidence J:354285
increased lymphoma incidence J:164200
\Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:117023
\Tg(IghMyc)22Bri/0
(involves: C57BL/6N * SJL) 		increased lymphoma incidence J:214383
\Tg(IghMyc)22Bri/0
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:89049
\Tg(IghMyc)22Bri/0
\Tg(Lck/Emu-Eif4e)#Ppp/0
(involves: C57BL * SJL) 		increased lymphoma incidence J:89878
\Tg(IghMyc)22Bri/0
\Trp53tm1Tyj/\Trp53+
(involves: 129/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
\Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh) 		increased B cell derived lymphoma incidence J:131912
\Tg(Igkv3-5-MYC)#Plbe/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:131912
\Tg(IGL-MYC)3Hm/0
(C57BL/6N-Tg(IGL-MYC)3Hm/Nci) 		increased B cell derived lymphoma incidence J:65245
\Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6) 		increased lymphoma incidence J:196403
\Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
\Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6) 		increased T cell derived lymphoma incidence J:73487
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6) 		increased T cell derived lymphoma incidence J:73487
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified) 		increased T cell derived lymphoma incidence J:144975
\Tg(Lck-Akt2*)#Test/0
(Not Specified) 		increased lymphoma incidence J:154583
increased T cell derived lymphoma incidence J:153923
\Tg(Lck-Id1)28Xhsu/0
(Not Specified) 		increased T cell derived lymphoma incidence J:58607
\Tg(Lck-LMO1)11Sjk/0
\Tg(STIL-TAL1)A5.3Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		increased T cell derived lymphoma incidence J:40868
\Tg(Lck-Map3k8)3456Ngc/?
(involves: C3H/HeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:39450
\Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2) 		increased lymphoblastic lymphoma incidence J:63300
increased T cell derived lymphoma incidence J:96010
\Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led) 		increased lymphoblastic lymphoma incidence J:36076
\Tg(Lck-Tax)53Hall/0
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:129531
\Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J) 		increased T cell derived lymphoma incidence J:93005
\Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6) 		increased T cell derived lymphoma incidence J:28635
\Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
\Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL) 		increased follicular lymphoma incidence J:69755
increased lymphoma incidence J:69755
increased T cell derived lymphoma incidence J:69755
\Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:51661
\Tg(Mdm2)1Snj/0
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:51661
\Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
\Tg(MMTV-Cdc37)1Stp/0
\Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6 * CD-1 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
\Tg(MMTV-Cdc37)2Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
\Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6J * CD-1) 		increased B cell derived lymphoma incidence J:62465
\Tg(MtTPRMET)243Lng/0
(FVB/N-Tg(MtTPRMET)243Lng) 		increased lymphoma incidence J:71573
\Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N) 		increased T cell derived lymphoma incidence J:17848
\Tg(SV40-NRAS*G12D)1Sco/?
(Not Specified) 		increased T cell derived lymphoma incidence J:125150
\Tg(SV)419Bri/\Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri) 		increased T cell derived lymphoma incidence J:147031
\Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:55022
increased T cell derived lymphoma incidence J:55022
\Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6) 		increased lymphoma incidence J:92992
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\Tg(tetO-BCR/ABL1)2Dgt/0
\Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:96511
\Tg(Thy1-cmyc)6Kio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
\Tg(Thy1-cmyc)6LKio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
\Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:189197
\Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat) 		increased lymphoma incidence J:257519
\Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		increased B cell derived lymphoma incidence J:88565, J:228913
increased follicular lymphoma incidence J:88565, J:228913
increased histiocytic sarcoma incidence J:88565
increased lymphoma incidence J:88565
increased T cell derived lymphoma incidence J:88565
\Tg(WapTgfa)215Bri/0
(B6.Cg-Tg(WapTgfa)215Bri) 		increased lymphoma incidence J:123146
\Tgfbitm1Zhao/\Tgfbitm1Zhao
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:143036
\Thbs1tm1Hyn/\Thbs1tm1Hyn
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391
\Thbs1tm1Hyn/\Thbs1tm1Hyn
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391
\ThimTg(Myh6-TGFB1)1Ljf/\Thim+
(involves: C3HeB/FeJ) 		increased T cell derived lymphoma incidence J:59903
\Thyls2MSM/\Thyls2MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:87704
\Tlag2AKR/J/\Tlag2C57L/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
\Tlag2AKR/J/\Tlag2C57L/J
\Tlag1AKR/J/\Tlag1AKR/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
\Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
\Tlr7em2Anu/\Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
\Tlsm1AKR/JMs/\Tlsm1AKR/JMs
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
\Tlsm1AKR/JMs/\Tlsm1SL/Kh
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
\Tmprss11dtm1Bug/\Tmprss11dtm1Bug
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		increased lymphoma incidence J:175364
\Tnk1tm1Sksuf/\Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:140639
\Tnk1tm1Sksuf/\Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:140639
increased lymphoma incidence J:140639
\Tpx2Gt(D028B03)Wrst/\Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased lymphoma incidence J:184948
\Trim37Gt(RRO307)Byg/\Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		increased lymphoma incidence J:232482
\Trim62tm1Akil/\Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:204336
\Trim62tm1Akil/\Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:204336
\Trp53Bbl/\Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased lymphoma incidence J:104190
increased T cell derived lymphoma incidence J:104190
\Trp53Bbl/\Trp53Bbl
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased B cell derived lymphoma incidence J:104190
\Trp53bhy/\Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu) 		increased lymphoma incidence J:104190
increased T cell derived lymphoma incidence J:104190
\Trp53tm1.1Awbr/\Trp53tm1.1Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
increased follicular lymphoma incidence J:169434
increased histiocytic sarcoma incidence J:173271
increased T cell derived lymphoma incidence J:173271
\Trp53tm1.1Brn/\Trp53tm3Tyj
\Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N * SKH1) 		increased lymphoma incidence J:121734
\Trp53tm1.1Thst/\Trp53+
\Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL * SJL) 		increased lymphoma incidence J:198482
\Trp53tm1.1Thst/\Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
\Trp53tm1.1Umol/\Trp53tm1.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
\Trp53tm1.1Xlu/\Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N) 		increased lymphoma incidence J:166152
\Trp53tm1.2Awbr/\Trp53+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
\Trp53tm1.2Awbr/\Trp53tm1.2Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
increased histiocytic sarcoma incidence J:173271
increased T cell derived lymphoma incidence J:173271
\Trp53tm1Brd/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:73757
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:51661
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:1999
increased T cell derived lymphoma incidence J:126497
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:157041
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:109585
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased lymphoma incidence J:141515
\Trp53tm1Brd/\Trp53tm1Ldo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:73757
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		increased lymphoma incidence J:162126
\Trp53tm1Elee/\Trp53tm1Elee
\Tg(MMTV-cre)AElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:90247
\Trp53tm1Gev/\Trp53tm1Gev
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:99305
\Trp53tm1Glo/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:61683
\Trp53tm1Glo/\Trp53+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:129627
\Trp53tm1Glo/\Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:61683
\Trp53tm1Glo/\Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
increased T cell derived lymphoma incidence J:171821
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:36762
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
\Trp53tm1Thst/\Trp53+
\Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * SJL) 		increased lymphoma incidence J:198482
\Trp53tm1Thst/\Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391, J:17728
\Trp53tm1Tyj/\Trp53+
\Trp53bp2tm1Xlu/\Trp53bp2+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J) 		increased lymphoma incidence J:108701
\Trp53tm1Tyj/\Trp53+
\Trp63tm1Fmc/\Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp53tm1Tyj/\Trp53+
\Trp73tm1Fmc/\Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp53tm1Tyj/\Trp53+
\Uimc1tm1.2Amj/\Uimc1tm1.2Amj
(involves: 129S2/SvPas * BALB/cJ * C57BL/6) 		increased lymphoma incidence J:191827
\Trp53tm1Tyj/\Trp53+
\Xrcc2tm1Pmc/\Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:111068
\Trp53tm1Tyj/\Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:72391, J:17728, J:95318
increased T cell derived lymphoma incidence J:87501, J:17728
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased lymphoma incidence J:221224
increased T cell derived lymphoma incidence J:251434, J:221224, J:88120, J:95316
\Trp53tm1Tyj/\Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased lymphoma incidence J:102483
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Ly6e-MALT1)#Isg/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc2tm1Pmc/\Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:111068
increased T cell derived lymphoma incidence J:111068
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas) 		increased B cell derived lymphoma incidence J:61973
\Trp53tm1Tyj/\Trp53tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
\Trp53tm1Tyj/\Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
\Trp53tm1Tyj/\Trp53tm3.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
\Trp53tm1Yjc/\Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		increased splenic marginal zone lymphoma incidence J:195018
\Trp53tm2.1Thst/\Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
increased T cell derived lymphoma incidence J:282255
\Trp53tm2.1Umol/\Trp53tm2.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
\Trp53tm2Glo/\Trp53tm2Glo
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:87501
\Trp53tm2Thst/\Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
increased T cell derived lymphoma incidence J:282255
\Trp53tm3.1Glo/\Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504, J:95318
increased T cell derived lymphoma incidence J:317504
\Trp53tm3.1Glo/\Trp53tm3.1Glo
(B6.129S7-Trp53tm3.1Glo) 		increased lymphoma incidence J:95318
\Trp53tm3.1Glo/\Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
\Trp53tm3.1Tyj/\Trp53+
(involves: 129S4/SvJae) 		increased B cell derived lymphoma incidence J:95316
\Trp53tm3Tyj/\Trp53+
\Tg(KRT14-cre)8Brn/?
(involves: 129S4/SvJae * FVB/N * SKH1) 		increased lymphoma incidence J:121734
\Trp53tm3Tyj/\Trp53+
\Tg(Wap-cre)11738Mam/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased lymphoma incidence J:101617
\Trp53tm4Glo/\Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
increased T cell derived lymphoma incidence J:171821
\Trp53tm4Tyj/\Trp53tm4Tyj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:92917
\Trp53tm4Xu/\Trp53tm4Xu
(Not Specified) 		increased lymphoma incidence J:126497
increased T cell derived lymphoma incidence J:126497
\Trp53tm6Xu/\Trp53tm6Xu
\Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		increased lymphoma incidence J:157041
increased T cell derived lymphoma incidence J:157041
\Trp53tm7.1Xu/\Trp53tm7.1Xu
(Not Specified) 		increased lymphoma incidence J:160414
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:82512
increased T cell derived lymphoma incidence J:82512
\Trp53bp2tm1Cdlo/\Trp53bp2+
\Tg(EmuSR-tTa)83Bop/0
\Tg(tetO-MYC)36aBop/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:146764
\Trp53bp2tm1Xlu/\Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lymphoma incidence J:108701
increased T cell derived lymphoma incidence J:108701
\Trp63tm1Fmc/\Trp63+
(involves: 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:98958
\Trp63tm1Fmc/\Trp63+
\Trp73tm1Fmc/\Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp73tm1Fmc/\Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp73tm1Mak/\Trp73+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:142848
increased T cell derived lymphoma incidence J:142848
\Trp73tm1Mak/\Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:142848
increased T cell derived lymphoma incidence J:142848
\Ts(16C-tel)1Cje/0
(involves: C57BL/6J * Rb(11.16)2H * Rb(16.17)32Lub) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
\Ts(1716)65Dn/0
(involves: C3H/HeJ * C57BL/6J * DBA/2J) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
\TsilTg(Myc)12ALvn/\Tsil+
(involves: C57BL/6 * SJL/J) 		increased lymphoma incidence J:33857
\Tusc2tm1Avi/\Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:119985
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:119985
\Ube2otm1.1(KOMP)Mbp/\Ube2otm1.1(KOMP)Mbp
\Ptentm1Ppp/\Ptentm1Ppp
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N) 		increased lymphoma incidence J:239679
\Ube2otm1.1(KOMP)Mbp/\Ube2otm1.1(KOMP)Mbp
\Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6N * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:239679
\Uimc1Gt(RRN158)Byg/\Uimc1Gt(RRN158)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:188388
\Uimc1tm1.2Amj/\Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6) 		increased B cell derived lymphoma incidence J:191827
increased lymphoma incidence J:191827
increased T cell derived lymphoma incidence J:191827
\Ungtm1Tld/\Ungtm1Tld
(Not Specified) 		increased B cell derived lymphoma incidence J:85353
\Usp44tm1.2Pjgl/\Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased lymphoma incidence J:193965
\WwoxGt(XG218)Byg/\WwoxGt(XG218)Byg
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:132078
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:44361
\Zeb1tm1Yhi/\Zeb1tm1Yhi
(either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR)) 		increased T cell derived lymphoma incidence J:139194
\Zfp14tm1Xch/\Zfp14+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
\Zfp14tm1Xch/\Zfp14tm1Xch
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
\Zfp36l1tm1.1Tnr/\Zfp36l1tm1.1Tnr
\Zfp36l2tm1.1Tnr/\Zfp36l2tm1.1Tnr
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL) 		increased T cell derived lymphoma incidence J:162388
\Zfp871tm1a(EUCOMM)Wtsi/\Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		increased B cell derived lymphoma incidence J:317166
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory